Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients

NCT05805072 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory AML

Interventions

DRUG: Selinexor
DRUG: Homoharringtonine
DRUG: Cytarabine
DRUG: Aclacinomycin
DRUG: Granulocyte Colony-Stimulating Factor
DRUG: Decitabine
DRUG: Azacitidine

Sponsor

The First Affiliated Hospital of Soochow University